The unit(s) of measurement applicable to the metric.
: Percentage (%)
Indicator
i
Indicators were developed by WBCSD. Learn more on the Methodology page.
: GHG emissions
Metric type
i
The category of nature-related metrics. Learn more on the Methodology page.
: Pressure
Framework alignment notes
i
The details of a metric’s alignment to each framework, including where the same or similar metric can be found within the listed framework.
E1-5 AR 34
HC-DR-130a.1.
Refer to the PSCI resources included in the Metric definition
Refer to the PSCI's Decarbonization Playbook for the Pharmaceutical Industry and Supplier Environmental Survey for alignment to the metric
T8
Target example
[Company name] will reduce its reliance on grid electricity by [target amount, as absolute MWh, or percentage] by [target date] compared with a [baseline year] baseline, through increased on-site renewable energy generation and procurement of clean energy sources
Target Source: WBCSD target template
Sector
i
Each metric applies to one sector.
Pharmaceutical
Value chain stage
i
Each metric applies to one or more stages of the value chain aligned with the associated actions.
Raw MaterialsManufacturing
Metric assessment
i
The relevance and feasibility scores were determined by WBCSD member companies. Learn more on the Methodology page.
Relevance:High
Feasibility:High
Related actions
Set time-bound, science-based GHG reduction targets that are externally verified and aligned with climate goals
Reduce GHG emissions from operations and land use activities
Develop and implement sourcing guidelines that prioritize sustainable commodities and suppliers committed to sustainable practices